author-photo

Rhonda L. Bitting

Wake Forest University

35

Papers

321

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

609P Treatment patterns and overall survival (OS) in metastatic castration-sensitive prostate cancer (mCSPC) from 2006 to 2019

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Interim analysis of STARTAR: A phase II salvage trial of androgen receptor (AR) inhibition with androgen deprivation therapy (ADT) and apalutamide with radiation therapy (RT) followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
BODY COMPOSITION, PHYSICAL FUNCTION AND QUALITY OF LIFE ACROSS DIFFERENT STAGES OF PROSTATE CANCER: A CROSS-SECTIONAL ANALYSIS: 3534 Board #355 May 29 2:30 PM - 4:00 PM

2020 Medicine and Science in Sports and Exercise
Show All
- Source
- Cite
- Save
Citations (0)
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial

2020 European Urology Oncology
Show All
- Source
- Cite
- Save
Citations (4)
High Adherence To Home-Based Exercise Improves Muscle Strength And Cardiorespiratory Fitness With Advanced Prostate Cancer: 74 Board #5 May 29 9:30 AM - 11:30 AM

2019 Medicine and Science in Sports and Exercise
Show All
- Source
- Cite
- Save
Citations (0)
Syntaxin 6‐mediated exosome secretion regulates enzalutamide resistance in prostate cancer

2019 Molecular Carcinogenesis
Show All
- Source
- Cite
- Save
Citations (12)
Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (19)
PD65-01 DO EXOSOMES CONTRIBUTE TO THE DEVELOPMENT OF ENZALUTAMIDE-RESISTANT PROSTATE CANCER?

2018 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (2)
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine

2018 Biochimica et Biophysica Acta
Show All
- Source
- Cite
- Save
Citations (64)